This inventor holds 55 USPTO granted patents and 1 published patent application and 4 EPO patents, primarily in Pharmaceutical Compounds (CPC class A61K). Top assignees: Kemphys Ltd., Research Foundation Itsuu Laboratory, Shionogi Company Limited. Active years: 1980-2019.
Inventors with similar research interests:
Location History:
- Totsukaku, Yokohama, JP (1980)
- Yokohamashi, Kanagawa, JP (1981)
- Kosugayacho, Totsukaku, Yokohamashi, Kanagawa, JP (1982)
- Totsukaku, Yokohamashi, Kanagawa, JP (1981 - 1983)
- Higashiyama, Meguroku Tokyo, JP (1987)
- Mishuku-jutaku Higashiyama, Meguro-ku, Tokyo, JP (1987)
- Higashiyama, Meguroku, Tokyo, JP (1988)
- Higashiyama, Megura-ku, Tokyo, JP (1995)
- Suginami-ku, Tokyo, JP (1997)
- Suginami-ku, Tokyo JP (1998)
- Tokyo-to, JP (2013)
- Tokyo, JP (1989 - 2019)
Company Filing History:
12 out of 12Â 
11 out of 14Â 
6 out of 1,001Â 
Years Active: 1980-2019
Areas of Expertise:
Title: **Koichi Shudo: Innovator in Neuropathic Disease Treatment**
Introduction
Koichi Shudo, based in Tokyo, Japan, is a prominent inventor known for his significant contributions to the field of medicinal treatments. With an impressive portfolio of 55 patents, Shudo has dedicated his career to developing innovative solutions for healthcare challenges, particularly in neuropathic diseases.
Latest Patents
Among his latest innovations is a medicament designed for the therapeutic treatment of neuropathic diseases. This medicament is formulated as an external preparation aimed at alleviating local symptoms associated with neuropathic conditions, utilizing either gabapentin or pregabalin in the form of an aqueous solution. His dual patent on this treatment highlights the effectiveness and importance of his work in addressing complex health conditions.
Career Highlights
Throughout his career, Shudo has worked at various reputable companies, including Kemphys Ltd. His extensive experience in the pharmaceutical industry has enabled him to refine his research and development skills, leading to groundbreaking inventions in the field of medicine.
Collaborations
Collaboration has been a key aspect of Shudo's career, working alongside talented professionals such as Katsuyoshi Iwamatsu and Yasuo Sato. These partnerships have fostered an environment of creativity and innovation, allowing for the development of effective treatments that benefit many patients.
Conclusion
Koichi Shudo continues to be a driving force in the development of therapeutic treatments for neuropathic diseases. His commitment to innovation is evident in his extensive patent portfolio and collaborative efforts with other skilled professionals. As the landscape of medical treatment evolves, Shudo's contributions remain vital to the advancement of healthcare.